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Recently there is an increasing interest in aspects of a more speciﬁc immunoregulation during pregnancy.
Understanding these mechanism might have a broader application not only for reproductive immu-
nology but also in general for biology and medicine. Especially the induction, already before conception,
of feto-speciﬁc T cells with a possibly regulatory function gives a biological explanation of local immu-
notolerance at the maternal fetal interface, supporting the epidemiological evidence of a feto/paternal-
speciﬁc immuneregulation. Understanding the expression of speciﬁc HLA-classes on trophoblast and the
crosstalk of these antigens with various cell types, speciﬁcally modulated in the decidua, resulting in the
secretion of cytokines and (angiogenic) chemokines has given us a more and more detailed under-
standing of this regulation. This regulation could be induced by fetal cells circulating in the mother
(microchimerism) and from the interaction with fetal subcellular fractions as exosomes, but also from
paternal antigens present in seminal ﬂuid. Molecular interaction between paternal and fetal antigens and
receptors in endometrium and the decidua are discussed.
This review highlights besides uNK cells, especially the function of CD4þ and CD8þ T cells with
a regulatory function in the context of recurrent miscarriage and pre-eclampsia. Besides HLA, also male-
speciﬁc minor histocompatibility antigens and the genetic background for these pregnancy complica-
tions are discussed.
 2011 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
The uncomplicated acceptance by the mother of her immuno-
logically foreign, semi-allogeneic fetus, is one of the enigmas of
human reproduction. The immunology of pregnancy is not only
intriguing but also an interesting model for transplantation. The
understanding of immunological mechanism involved in tolerance
induction during pregnancy might help to design future strategies
for the prevention of graft rejection and complications associated
with the need of long-term immunosuppression.
Recent experimental evidence support epidemiological data
[1] that already before implantation fetus speciﬁc tolerance is
induced for paternally derived antigens. The importance of T cells
with a regulatory function, locally active in the decidual lining of
the uterus, is only recently appreciated [2,3]. The role of immu-
nomodulatory T cells in reproductive biology is of central
importance also for the understanding of immunological memory,ical Center, Department of
x 9600, 2300 RC Leiden, The
41.
.
Elsevier OA license.a well appreciated phenomenon in human reproduction, however,
far from completely understood. The expression of paternal
antigens on invading fetal trophoblast and their interaction with
not only uterine NK cells but also with T cells, might not only be
responsible for both non-speciﬁc- and speciﬁc-suppression of the
anti-fetal cytotoxic T cell responses, but also for long-term
immunological memory. Also the possible role of macrophages,
being part of this immunological network in the uterus during
(human) pregnancy, in these immunomodulatory processes is not
yet fully appreciated [4]. Studies on the actual presence and
phenotypes of these T cells and their function in relation to
genetic differences (polymorphisms) between mother and her
child will help to understand the immune mechanisms involved
in fetal-maternal immunoregulation.2. Human leuckocyte antigens (HLA), immune modulation
and angiogenesis
The key mechanism for the escape of maternal rejection and
for the induction of tolerance lies in the aberrant expression of
HLA molecules by trophoblast cells. Extravillous trophoblast
(EVT) cells, migrating into the decidua, express an unusual
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classical, monomorphic HLA-E, -F and -G. Already in the early
1980s it was shown that EVT cells are positive for W6/32, an
antibody common for the HLA-A, -B and -C antigen, although it
was not realized e as it later turned out e that it was only HLA-C
which is expressed on EVT [5,6]. Villous syncytiotrophoblast does
not express HLA class I and e as EVT cells e HLA class II. Limited
information is available on the expression of soluble class I MHC
antigens during pregnancy with the exception of s-HLA-G [7].
Soluble HLA-G5 (sG1) and soluble HLA-G6 (sG2) induce apoptosis
of activated T cells, especially CD8þ T cells [8,9]. HLA-DR
expression in villous stroma, amnion and in the decidua is
restricted to cells with a macrophage morphology [10] and does
not include trophoblast cells. At the fetal-maternal interface the
invading trophoblast encounters a wide range of maternal tissue
leukocytes: including speciﬁc uterine NK cells (uNK), macro-
phages, dendritic cells and T cells. HLA molecules are able to
interact with speciﬁc receptors on these leukocytes, stimulating
the production of several cytokines (i.e. TGF-b), chemokines and
angiogenic factors, such as VEGF, PlGF, IL-8, angiopoietins (Ang1
and 2) [11]. By these mechanism the maternal immune response
is modulated in a characteristic way, promoting trophoblast
invasion which is essential for normal implantation and for
changes in blood vessel development (e.q. the spiral arteries).
Invasion of trophoblast is a highly delicate balance. A deep
trophoblast invasion is associated with a placenta increta; an
inadequate trophoblast invasion and insufﬁcient remodeling of
the spiral arteries is seen in pre-eclampsia (PE), one of the most
severe complications of pregnancy. Pathogenesis of complica-
tions of pregnancy such as recurrent spontaneous abortions
(RSA) e not in the context of chromosomal abnormalities e,
implantation failure or intrauterine growth restriction (IUGR) is
shared with pre-eclampsia, thought to be all resulting from
abnormal trophoblast invasion. As one of the possible common
immunological pathways, the effects of interaction between
maternal KIR receptors and fetal HLA-C polymorphisms is well
established. Inhibition of maternal uNK cell function will prevent
a proper invasion of trophoblast into the decidua. As we recently
demonstrated the presence of KIR receptors on T cells, especially
on decidual tissue derived T cells, this mechanism might also be
functional in T cell regulation [12].2.1. HLA sharing
HLA sharing between partners will lead to HLA homozygosity in
the fetus and as a result less HLA incompatibility with the mother.
This can affect the maternal immune response already at the time
of mating and conception as well as during implantation and
throughout pregnancy. HLA compatibility is thought to be more
prevalent in women with implantation failure. This might partly
explain RSA and PE. However also genetic explanations are sug-
gested, whereby homozygosity of lethal recessive genes, in linkage
disequilibriumwith speciﬁc HLA haplotypes, might be implied [13].
Genes coding for some of the molecules involved in the immune
response in human, such as TNF-a, are located within the HLA
complex on chromosome 6. As a consequence HLA haplotypes
could be just indicator genes for linked genes coding for cytokines
such as TNF-a.
An association between fetal-maternal HLA compatibility,
decreased anti-paternal antibodies levels, speciﬁc HLA alleles, or
combinations of KIR receptors in the mother and HLA-C alleles in
the fetus and inadequate trophoblast invasion suggest that these
are risk factors associated with implantation failure and pregnancy
complications.2.2. Microchimerism
Epidemiological studies have demonstrated that rheumatoid
arthritis patients tend to show clinical improvements during
pregnancy, especially if the level of class II matches between
mother and child is higher [14]. This suggests a role for paternal
antigens in the modulation of the maternal immune response
during pregnancy. These antigens must be derived from fetal cells
trafﬁcking into the mother during pregnancy, which will persist life
long [15]. Even fully HLAmismatched, allogeneic fetal cells entering
during donor egg pregnancies persist for many years after delivery
in the circulation of healthy women, suggesting an immunomod-
ulatory mechanism preventing the deletion of these cells from the
host [16]. The persistence of a small population of foreign cells in
another individual, microchimerism, is well recognized both after
organ transplantation [17] and after pregnancy, whereby fetal
microchimerism during pregnancy is a natural consequence of
pregnancy. There is a potential important role of feto-maternal cell
trafﬁcking, fetal microchimerism or placental exosomes or micro-
particles and (the level of) anti-paternal antibodies in the induction
of host tolerance (in the mother) to her pregnancy (graft tissue)
[17e20]. The immunogenicity of these paternal HLA antigens is
dependent on the HLA phenotype of the mother: on average
15e30% of womenwho have been pregnant produce antibodies but
certain combinations of fetal and maternal HLA generate signiﬁ-
cantly more antibodies [21]. This sensitization is associated with
the generation of cytotoxic T cells speciﬁc against paternal antigens
[22]. Successful pregnancy could be characterized by the develop-
ment in the mother of some degree of leukocyte chimerism-
dependent, donor speciﬁc tolerance. Central tolerance induction
via positive and negative selection of chimeric T cells in the thymus
could modify the generation of speciﬁc T cell clones and could be
important in controlling the immune response. In themousemodel
is shown that maternal peripheral T cells become tolerant to
speciﬁc paternal antigens. However, this immunological tolerance
is transient, and the situation is reversed directly after delivery [23].
As after delivery pregnancy induced immunomodulation is lost,
these activated fetal cells in maternal tissue might trigger the later
development auto-immune disease in the mother such as auto-
immune thyroid disease and systemic sclerosis.
2.3. T cells
Studies in the mouse model gave strong arguments that fetal/
placental antigen presentation and recognition of fetal antigens by
CD4þ T cells is exclusively by indirect recognition. This is not
surprising, as the placenta has no MHC class II expression, making
the direct antigen presentation via CD4þ cells impossible. In human
pregnancy a HLA-C mismatch leads to an increase in CD4þCD25dim
activated T cells and the presence of functional CD4þCD25bright
regulatory T cells [24]; in HLA-C matched pregnancies no such
proliferation is found. As CD4þ cells are involved, this supports that
also in human pregnancy (peptides processed from) HLA-C alleles
are recognized indirectly and presented in the context of self MHC
class II on maternal APCs. HLA-C, which is highly polymorphic, can
elicit (in- and outside) pregnancy allogeneic T cell responses; one of
themechanism explaining tolerance and absence of rejection of the
fetal allograft in uncomplicated pregnancies. In the decidua CD8þ
cells is the most abundant T cell type [25]. However, CD8þ cells are
MHC class I restricted and may directly recognize intact HLA-C on
allogeneic fetal cells. HLA-C speciﬁc receptors have been demon-
strated on decidual T cells [12], most possibly affecting their cytoxic
potential. Potential other targets for CD8þ cells are HLA-E and
minor histocompatibility antigens. Also the decidual CD8þCD28
subset includes besides activated effector and effector-memory
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the decidua are almost absent [26]. In decidual CD8þCD28
a substantial reduced expression of the cytolytic molecules perforin
and granzyme B were demonstrated precluding cytotoxic
responses of these cells in human decidua [26,27].
CD8þCD28CD103þ which are present in decidual isolates have
a potential regulatory function can be induced directly by fetal
trophoblast [27].
Besides T cells, several other immunocompetent cells e inter-
acting with T cells e are active in human decidual tissue. In early
decidua around 40% of the stromal cells are leukocytes, of which
45e70% are NK cells, 30% are macrophages and fewer than 20e30%
are CD3þ T lymphocytes [28]. Although through pregnancy the
CD3þ fraction remains stable, the largest immune cell population in
the 3rd trimester is CD3þ, because the number of NK cells is
decreasing [28].
T-helper cells (TH) can be classiﬁed by the cytokines they are
producing as TH1 cells, involved in cellular immunity and cells
involved in humoral immunity, the TH2 cells. More recently T
regulatory cells (Tregs) and TH17 subsets were described. Wegman
et al. were the ﬁrst who suggested that in normal pregnant mice,
pregnancy is characterized by a dominance of the TH2 over the TH1
type immune response [29]. In human endometrial samples taken
peri-implantation a TH2 dominance was found; however no local
TH2 dominance could be demonstrated in term decidual samples
acquired before or after labor. Because of this and although there is
evidence that, because of this TH2 dominance, e.g. infectious
defends mechanism in peripheral blood of normal pregnant
women is reduced, the concept is debated. A TH2 dominance shift is
probably less extreme or could even not be found in women with
complicated pregnancies [30]. Using lymphocyte function markers
in e unstimulated e peripheral blood samples, no change in pre-
eclampsia patients in the TH1/TH2 ratio could be demonstrated,
although there was an increase in TH2 cells in normal pregnancies.
2.4. Regulatory T cells
Regulatory T cells are cells with immune suppressive properties
of which at least four different subsets have been described: Tr1
(type I regulatory T cells), TH3 (T-helper 3) cells, the natural arising
regulatory Tcells (Tregs), and CD8þ cells with regulatory properties.
Non-speciﬁc circumstances, such as sub-optimal antigen presen-
tation and hormonal factors (elevated estrogen levels around
ovulation and a speciﬁc hormonal milieu e.g. high progesterone
levels), together with paternal alloantigens [31], result in expansion
of these regulatory cells [32].
Tregs are essential for natural self-tolerance and characterized
by the surface expression of CD4 and CD25 (IL-2R a-chain). In
addition to a high expression of CD25 they express cytotoxic T
lymphocyte antigen (CTLA-4 ¼ CD152) and other surface markers
such as GITR, OX40, CD62, CD38, CD122, CD132. Intracellularly the
transcription factor Foxp3 is expressed. The important role of
especially Tregs in the development of maternal tolerance is shown
both in animal models and in human tissues; the role of the other 3
subsets is probably more redundant or has further to be elucidated
[32].
It is most likely that the Tregs also in humans are induced in
peripheral lymphoid tissues and not in the thymus and that e.g.
fetal antigens can drive the expansion of the Treg pool. Foxp3
expression is critical for their development and for their regulatory
function [33]. A mutation in the Foxp3 gene results in mice in the
loss of regulatory function. It was shown in early human pregnancy
decidual tissue, that these Tregs also have a high expression of
CTLA-4. They mediated e most probably via cellecell contact e T
cell inhibition in a dose dependent manner, most probably viamembrane bound TGF-b and IL-10, but possibly by other regulatory
candidate binding molecules such as Lag-3 and galectin-1. IDO
expression has been shown in many studies to be of importance in
tolerance induction, although this role is also disputed [34]. CTLA-4
expression by Tregs might play a role in competing with the co-
stimulatory molecule CD28 via binding B7-1 (CD80) and B7-2
(CD86) and in the upregulation of IDO expression by dendritic
cells and macrophages.
In humans the subset of CD4þCD25bright has a regulatory
potential as shown by the suppression of proliferation of CD4þ cells
in vitro [3].
2.5. Semen
The induction of pre-conception, pre-implantation T cell
mediated immune modulation via the expansion of paternal
speciﬁc CD4þ and CD8þ cells by paternal antigens present in
seminal ﬂuid is demonstrated in the mouse model [35].
Surprisingly there is only suppression after intravaginal immu-
nization, while subcutaneous immunization remains ineffective.
Semen contains both MHC class Ia, Ib and class II, possibly
expressed on seminal leukocytes or cellular fractions (exosomes).
In combinationwith immunomodulatory factors such as TGF-b or
PGE2 in the seminal ﬂuid, paternal speciﬁc immunomodulation is
induced. Paternal antigens can be presented directly via paternal
APCs in semen or indirectly via maternal APC to maternal T cells.
As no Foxp3þ cells were present in the vagina mucus these APC
probably travel to peripheral lymph node where Tregs are
generated. Naïve CD4þCD25 T cells become Tregs, when they are
stimulated in the presence of TGF-b or PGE2. Estrogen leads to
increased production of TGF-b, which especially during the
secretory phase, modulates anti-paternal T cells responses [36]
(Fig. 1). In mice Tregs are already found in draining lymph
nodes within two days after mating [37], combined with an
upregulation of Foxp3 expressing cells and Foxp3 mRNA in the
uterus. Interestingly, seminal ﬂuid is able to inhibit rejection of
tumor cells with a same MHC background [38].
3. Endometrium and decidua
3.1. Preimplantation changes in endometrium
As Tregs are expanded already before implantation, speciﬁc T cell
receptors important for pregnancy regulation, like immunoglobulin-
like transcript2 (ILT-2), killer cell immunoglobulin-like receptors
(KIR) and receptors for e.g. HLA-G (NKG receptors) should be trig-
gered by circulating molecules around conception. These receptors
are found on T cells [12] and soluble class I MHC (sMHC-I), found in
serum and semen of healthy individuals, can trigger these receptors.
Tregs express the chemokine receptor CCR4 and CCR8 [39] and CCR5,
which are of importance for trafﬁcking of Tregs into the decidual
tissue. Uterine endometrium does express the chemotactic factor
CCL4 which attracts Tregs via its ligand CCR5. CCL4 is increasing
during the estrus mouse cycle and there is a direct association
between CCL4 levels and the expression of Foxp3 in the uterus,
which is explaining by a selective attraction of CCR5þ Tregs in the
endometrium (Fig. 2a). CCL17which is highly expressed in the uterus
is important for the interaction with macrophages, which then
produce the ligand CCL22, of importance for the homing of Tregs into
the decidua [40]. Local production of other chemokines such as
CXCL9, CXCL10 (and CCL4) trigger the inﬂux of uNK cells; CXCL16 is
a factor attracting monocytes and T cells into the endometrium/
decidua [41]. CXCR6 -which is the sole receptor for CXCL16- is
expressed by Tcells andmonocytes. Tregs accumulate periodically in
the endometrium and peak during estrus [31]. In human
Fig. 1. Schematic representation of factors inﬂuencing the induction of Tolerogenic T cells during mating and pregnancy.
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increase already in the late follicular phase of the menstrual cycle,
possibly related to serum estradiol levels followed by a substantial
decrease of Tregs in the luteal phase [42].
3.2. Postimplantation changes in the decidua
Increases of the CD4þCD25þ subsets in early human decidua
pregnancy [43], with a further increase in the second [44,45] and
third trimester [45] (Fig. 2c) were described by several groups
[46]. They gradually return to lower levels postpartum [47]. No
such increases are found in the systemic circulation as Tregs in
non-pregnant individuals and pregnant controls are the same
and signiﬁcantly lower than percentage found in decidual tissue
(Fig. 2b).Fig. 2. Changes in endometrial-decidual contribution of cells with a regular phenotype du
pregnancy (Fig. 2b) compared to peripheral samples from non-pregnant and pregnant con4. Immunology and pregnancy complications
4.1. Miscarriage
RSA is affecting 1% of couples attempting pregnancy. Meta-
analysis does not show that sharing between couples of any
speciﬁc HLA allele is a signiﬁcant or important risk factor for RSA
[13]. An increased risk of sharing is suggested for HLA-A (OR 1.4;
95% CI 0.95e2.05) and for HLA-DR, sharing of least one allele is
associated with an increased risk (OR 1.3; 95% CI 1.01e1.75).
Carriage of HLA-DR1 or HLA-DR2 in combination with HLA-
G*010102 allele is associated with an increased risk (OR 4) for RSA
[48]. This association possibly reﬂects a genetic interaction with
other genes, e.g. for cytokines, MBL2 [49] or thrombotic disease, in
the same genetic region. Also studies of HLA-G sharing and ofring (Fig. 2a) menstrual cycle and pregnancy in mice (from Ref. [31]) and in human
trol samples (from Ref. [45]).
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bility as a factor for RSA. In women having an abortion after IVF
treatment lower sHLA class I and class II levels compared to control
intact pregnancies were found [50], whereby a TH2 cytokine
response is associated with increased sHLA class II levels. Maternal
SNP variations in the promoter of HLA-G might inﬂuence HLA-G
expression, associated with RSA [51]. Immunohistochemically no
differences in HLA-G or HLA-E expression was demonstrated
between tissue samples from RSA patients and controls [52]. Both
in RSA couples and PE parents the frequency of HLA-C2 in the fetus
is increased while the KIR AA (inhibiting) genotype frequencies in
the women is also increased [53,54]. Activating KIR genotypes for
HLA-C2 such as KIR2DS1 are reduced (OR 2.63 95% CI 1.54e4.49)
[54]. Also having amale ﬁrst bornmight induce amaternal immune
response against the male-speciﬁc minor histocompatibility (HY)
antigens associated with a negative effect on pregnancy success.
This is found only in secondary RSAwomen carrying HY-restricting
HLA class II alleles (OR 0.35; 95% CI 0.2e0.7) [55,56]. This suggests
a possible role for CD4þ T cells in providing help for CD8þ cytotoxic
T cells against minor H antigens.
Although possibly harmful during mid- and late- gestation, the
inﬂammatory response associated with small amounts of TH1
cytokines might be of advantage during implantation. Gonadotro-
phins induce cytokines such as TNF-a and IFN-g, which are both
also produced by the blastocyst. IL-10 production, which is known
to reduce spontaneous abortion in the CBA x DBA/a abortionmodel,
is only increased after implantation and is produced by the tro-
phectoderm and the inner cell mass.
Tregs are needed for a successful allogeneic pregnancy in mice.
These Tregs expand during pregnancy, induced by paternal anti-
gens, and prevent rejection of the fetus [37]. In an abortion prone
mouse model decidual tissue was shown to contain IFN-g
producing T cells (TH1 cells), speciﬁc for paternal alloantigen. Their
presence is possibly related to an insufﬁcient induction of Tregs
during pregnancy. Tregs from normal pregnant mice could inhibit
proliferation [57] and IFN-g secretion and other TH1 cytokines such
as IL-2 [39,58] by these TH1 cells. Transfer of Tregs was shown to
prevent fetal resorption in this micemodel [34,57] in an alloantigen
speciﬁc manner, most probably by enhancing TH2 cytokine
production (IL-4 and IL-10) [58]. This speciﬁc ﬁnding was not
supported by other studies, where especially the induction of
TGF-b, neurophilin-1 [34,59], leukemia inhibiting factor and heme-
oxygenase-1 [34], created a tolerant microenvironment, while the
levels of IDO remained unchanged. In this mouse model the fetus
seems also to be protected via linked immunosuppression for
minor antigens [59] Fig. 2.
In RSA patients, both in peripheral blood samples and in the
decidua reduced levels of CD4þCD25þ Tregs were found [60]. Both
in peripheral blood and in the decidua the proportion of Tregs were
found to be lower in RSA patients and in non-pregnant controls
compared to normal pregnant controls [43,61].
RSA patients have substantial lower percentage of Tregs in the
systemic circulation [42] and in the decidua [39], comparable to
postmenopausal levels, both in the follicular phase and in the luteal
phase. Also the functional capacity of these suppressor cells is
lower [42]. The ratio of CTLA4þ/CD28þ in peripheral blood and in
the decidua is signiﬁcantly lower in miscarriage compared to
controls and is higher in Tregs (CD4þCD25þþ) suggesting that Tregs
support pregnancy via upregulation of CTLA-4 [39].
4.2. Pre-eclampsia
Epidemiological studies strongly suggested an immunological
basis for PE [62]. Changing partner, artiﬁcial donor insemination
and oocyte donation all increase the risk of hypertensive disordersin pregnancy, while there is a protective effect of prolonged period
of semen exposure. It is now evident that interaction between HLA-
C ligands on fetal trophoblast cells and KIR receptors on maternal
cells is of crucial importance for remodelling of spiral arteries and
immune modulation. Evidence for a common genetic etiology
contributing to the pathogenesis of PE, suggesting that recessive
mutations may play a role, is supported by the ﬁnding of the higher
incidence in women related to the patient compared to controls
[63]. It remains unclear if any speciﬁc HLA allele, haplotype or gene
in linkage disequilibriumwith the HLA region is associated with PE,
although cumulative evidence is suggesting that (homozygosity at)
the HLA-DR locus [64], especially HLA-DR4 [65], might be associ-
ated with PE [66]. Other genetic backgrounds such as heterozy-
gosity of the CTLA-4 allele, associations with the 1082G allele of the
IL-10 gene and a decrease in the AA homozygous genotype in the
promoter region of the IL-10 gene might predispose to PE [67],
while it is also likely that women who carry certain cytokine
polymorphisms, such as the upregulating TNFa-308 A/A genotype
or the IL-1a-producing-4845 G/G genotype make them more
susceptible for PE [68].
In peripheral blood samples from patients with PE lower levels of
CD4þFOXP3þ Treg cells have been found, although no differences in
the CD4þCD25bright subset could be demonstrated [69,70]. Also no
differences in CD4þ cells staining positive either for GITR or CTLA-4
could be demonstrated [69]. This is suggesting that even in severe
pregnancies complications there are no large differences in systemic
Tregs and that for the immunological changes especially local
mechanism should be important. This is shown in PE patients
having decreased numbers of CD4þCD25high T cells in decidual
tissue e and in peripheral blood [71,72].
5. Conclusion
Understanding of fetus speciﬁc tolerance induction during
pregnancy may lead to new tools also for the induction of donor
speciﬁc tolerance in the transplantation setting. A potential
problem is the fact that heavy post-transplant immunosuppression
for conventional organ transplantationmight be anti-tolerogenic as
it is also effecting the function and level of Tregs.
In pregnancy complications, so far the important issue of
differences between local immuneregulation versus systemic
changes in the immune response have insufﬁciently been taken
into account. As PE has pathophysiological pathways resembling
a systemic inﬂammatory response, it is reasonable to accept
changes in the systemic regulation during PE. However, these
changes might be different locally, at the fetal-maternal interface
and systemic changes might be rather the consequences of the
disease than the cause. Epidemiological ﬁndings in PE suggest
a more prominent role for T cells in the disease and especially the
putative role of Tregs in modulating the immune response and
understanding also immunological memory in this disease may
lead to important new biological concepts.
Conﬂict of interest
The authors state they have no conﬂict of interest.
References
[1] Kho EM, McCowan LME, North RA, Roberts CT, Chan E, Black MA, et al, on
behalf of the SCOPE consortium. Duration of sexual relationship and its effect
on preeclampsia and small for gestational age perinatal outcome. J Reprod
Immunol 2009;82:66e73.
[2] Sindram-Trujilo A, Scherjon S, Kanhai K, Roelen D, Claas F. Increased T cell
activation in decidua parietalis compared to decidua basalis in uncomplicated
human term pregnancy. Am J Reprod Immunol 2003;49:261e8.
S. Scherjon et al. / Placenta 32 (2011) S291eS297S296[3] Tilburgs T, Roelen DL, de Groot-Swings GM, Kleijburg C, Scherjon SA,
Claas FHJ. Evidence for a selective migration of fetus-speciﬁc CD4þ/
CD25bright regulatory T cells from the peripheral blood to the human preg-
nancy. J Immunol 2008;180:5737e45.
[4] Schonkeren D, van der Hoorn M-L, Khedoe P, Swings G, van Beelen E, Claas F,
et al. Differential distribution and phenotype of decidual macrophages in
preeclamptic versus control pregnancies. Am J Pathol; 2011. DOI:10.1016/
j.ajpath.2010.10.011.
[5] Sunderland CA, Redman CWG, Stirrat GM. HLA A, B, C antigens are expressed
on nonvillous trophoblast on the early human placenta. J Immunol 1981;127:
2614e5.
[6] Huddleston H, Schust D. Immune interactions at the maternal-fetal interface:
a focus on antigen presentation. Am J Reprod Immunol 2004;51:283e9.
[7] Puppo F, Costa M, Contini P, Brenci S, Cevasco E, Ghio M, et al. Determination
of soluble T cell HLA-G and HLA-A, -B and -C molecules in pregnancy. Transpl
Proc 1999;31:1841e3.
[8] Zavazava N, Hausmann R, Muller-Ruchholtz W. Inhibition of anti-HLAB7
alloreactive CTL by afﬁnity puriﬁed soluble HLA. Transplantation 1991;31:
838e42.
[9] Solier C, Aguerre-Girr M, Lenfant F, Campan A, Berrebi A, Rebmann V, et al.
Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1. Eur J Immunol
2002;32:3576e86.
[10] Sutton L, Mason DY Redman CWG. HLA-DR positive cells in the placenta.
Immunology 1983;49:103e12.
[11] Smith SD, Dunk CE, Aplin JD, Harris LK, Jones RL. Evidence for immune cell
involvement in decidual spiral artery remodelling in early human pregnancy.
Am J Pathol 2009;174:1959e71.
[12] Tilburgs T, van der Mast BJ, Nagtzaam NMA, Roelen DL, Scherjon SA, Claas FHJ.
Expression of NK cell receptors on decidual T cells in human. J Reprod
Immunol 2009;80:22e32.
[13] Beydoun H, Saftlas AF. Association of human leucocyte antigen sharing with
recurrent spontaneous abortions. Tissue Antigens 2005;65:123e35.
[14] Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA.
Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-
induced amelioration of rheumatoid arthritis. N Engl J Med 1993;329:466e71.
[15] Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal
progenitor cells persist in maternal blood for as long as 27 years postpartum.
Proc Natl Acad Sci U S A 1996;93:705e8.
[16] Williams Z, Zepf D, Longtime J, Anchan R, Broadman B, Missmer SA, et al.
Foreign fetal cells persist in the maternal circulation. Fertil Steril; 2008.
[17] Starzl Th E, Murase N, Thomson A, Demetris AJ. Liver transplants contribute to
their own success. Nat Med 1996;2:163e5.
[18] Starzl Th E. Acquired immunological tolerance: with particular reference to
transplantation. Immunol Res 2007;38:6e41.
[19] Triulzi DJ, Nalesnik MA. Microchimerism, GVHD, and tolerance in solid organ
transplantation. Transfusion 2001;41:419e26.
[20] Yunis EJ, Zuniga J, Romero V, Yunis EJ. Chimerism and tetragametic chimerism
in humans: implications in autoimmunity, allorecognition and tolerance.
Immunol Res 2007;38:213e36.
[21] Dankers MKA, Roelen DL, Korfage N, de Lange P, Witvliet M, Sandkuijl L, et al.
Differential immunogenicity of paternal HLA Class I antigens in pregnant
women. Hum Immunol 2003;64:600e6.
[22] Van Kampen CA, Versteeg-van der Voort Maarschalp MFJ, Langerak-
Langerak J, van Beelen E, Roelen DL, Claas FHJ. Pregnancy can induce long-
persisting primed CTLs speciﬁc for inherited paternal HLA antigens. Hum
Immunol 2001;62:201e7.
[23] Tafuri A, Alferink J, Möller P, Günthger J, Hämmerling J, Arnold B. T cell
awareness of paternal alloantigens during pregnancy. Science 1995;270:630e3.
[24] Tilburgs T, Scherjon SA, van der Mast BJ, Haasnoot GW, Versteeg-van der
Voort-Maarschalk M, Roelen DL, et al. Fetal-maternal HLA-C mismatch is
associated with decidual T cell activation and induction of functional T
regulatory cells. J Reprod Immunol 2009;82:148e57.
[25] Tilburgs T, Claas FH, Scherjon SA. Elsevier trophoblast research award lecture:
Unique properties of decidual T cells and their role in immune regulation
during human pregnancy. Placenta 2010;31(Suppl.):S82e6.
[26] Tilburgs T, Schonkeren D, Eikmans M, Nagtzaam NM, Datema G, Swings GM,
et al. Human decidual tissue contains differentiated CD8þ effector-memory T
cells with unique properties. J Immunol 2010;185:4470e7.
[27] Tilburgs T, Scherjon SA, Roelen DL, Claas FH. Decidual CD8þCD28 T cells
express CD103 but not perforin. Hum Immunol 2009;70:96e100.
[28] Williams PJ, Searle RF, Robson SC, Innes BA, Bulmer JN. Decidual leucocyte
populations in early to late gestation normal human pregnancy. J Reprod
Immunol 2009;82:24e31.
[29] Wegmann TG, Lin H, Guilbert L, Mossmann TR. Bidirectional cytokine inter-
actions in the maternal-fetal relationship: is successful pregnancy a TH2
p.enomenon? Immunol Today 1993;14:353e6.
[30] Anthanassakis I, Vassiliadis S. Interplay between T helper type 1 and type 2
cytokines and soluble major histocompatibility complex molecules: a para-
digm in pregnancy. Immunology 2002;107:281e7.
[31] Kallikourdis M, Betz AG. Periodic accumulation of regulatory T cells in the
uterus: preparation for the implantation of a semi-allogeneic fetus? PLoS ONE
2007;2:e382.
[32] Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance in
pregnancy: a new target for infertility treatment? Hum Reprod Update 2009;
15:517e35.[33] Sakaguchi S. Natural arising CD4þ regulatory T cells for immunologic self-
tolerance and negative control of immune responses. Annu Rev Immuno
2004;l22:531e62.
[34] Zenclussen AC, Gerlof K, Zenclussen ML, Ritschel S, Zambon Bertoja A, Fest S,
et al. Regulatory T cells induce a privileged tolerant microenvironment at the
fetal-maternal interface. Eur J Immunol 2006;36:82e94.
[35] Moldenhauer LM, Diner KR, Thring DM, Brown MP, Hayball JD, Robertson SA.
Cross-presentation of male seminal ﬂuid antigens elicits T cell activation to
initiate female immune response to pregnancy. J Immunol 2009;182:
8080e93.
[36] Seavy MM, Mosmann TR. Paternal antigen bearing cells transferred during
insemination do not stimulate anti paternal CD8þ T cells: role of estradiol in
locally inhibiting CD8þ T cell responses. J Immunol 2006;177:7567e78.
[37] Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal
tolerance to the fetus. Nat Immunol 2004;5:266e71.
[38] RoberstonSA,GuerinLR,Bromﬁeld JJ, BransonKM,AhlstromAC, CareAS. Seminal
ﬂuid drives expansion of the CD4þ CD25 T regulatory cell pool and induces
tolerance to paternal alloantigens in mice. Biol Reprod 2009;80:1036e45.
[39] JinLP Chen QY, Zhang T, Guo PF, Li DJ. The CD4(þ)CD25(bright) regulatory T
cells and CTLA-4 expression in peripheral and decidual lymphocytes are down
regulated in human miscarriage. Clin Immunol 2009;133:402e10.
[40] Laudansk P, Lemancewicz A Pierzynski P, Akerlund M, Laudanski T. Decreased
serum levels of macrophage inﬂammatory chemokines-3b/CCL19 in preterm
labor and delivery. Europ J Obstet Gynecol Reprod Biol 2006;124:23e6.
[41] Huang Y, Zhu X-Y, Du M-R, Li D-J. Human trophoblast recruited T lymphocytes
and monocytes into the decidua by secretion of chemokine CXCL16 and the
interaction with CXCR6 in the ﬁrst-trimester pregnancy. J Immunol 2008;180:
2367e75.
[42] Arruvito L, Sanz M, Banham A, Fainboim L. Expansion of CD4þCD25bright and
FOXP3þ regulatory T cells during the follicular phase of the menstrual cycle:
implications for human reproduction. J Immunol 2007;178:2572e8.
[43] Sasaki Y, Sakai M, Miyazaki S, Higuma A, Shiozaki A, Saito S. Decidual and
peripheral blood CD4þCD25þ regulatory T cells in early pregnancy subjects
and spontaneous abortion cases. Mol Hum Reprod 2004;10:347e53.
[44] Heikkinen J, Mottonen M, Alanen A, Lassila O. Phenotypic characterization of
regulatory T cells in the human decidua. Clin Exp Immunol 2004;136:373e8.
[45] Tilburgs T, Roelen DL, van der Mast BJ, van Schip JJ, Kleijburg C, Groot-
Swings GM, et al. Differential distribution of CD24(þ)/CD25(bright) and
CD8(þ)/CD28() T-cells in decidua and maternal blood during human preg-
nancy. Placenta 2006;27(Suppl. A):S47e53.
[46] Saito S, Sasaki Y, Sakai M. CD4þCD25high regulatory T cells in human preg-
nancy. J Reprod Immunol 2005;65:111e1120.
[47] Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human
pregnancy is associated with an elevation in the immune suppressive
CD4þCD25þ regulatory T-cell subset. Immunology 2004;112:38e43.
[48] Hvid TV, Christiansen OB. Linkage disequilibrium between human leucocyte
antigen (HLA) class II and HLA-G e possible implications for human repro-
duction and autoimmune disease. Hum Immunol 2005;66:688e99.
[49] Christiansen OB, Nielsen HS, Lund M, Steffensen R, Varming K. Mannose-
binding lectin-2 genotypes and recurrent late pregnancy losses. Hum Reprod
2009;24:291e9.
[50] Pfeiffer KA, Regmann V, Passler M, van der Ven K, van der Ven H, Krebs D,
et al. Soluble HLA levels in early pregnancy after in vitro fertilization. Hum
Immunol 2000;61:559e64.
[51] Berger DS, Hogge WA, Barmada M, Ferrell RE. Comprehensive analysis of HLA-
G; implications for recurrent spontaneous abortion. Reprod Sci 2010;17:
331e8.
[52] Bhalla A, Stone PR, Liddell HS, Zanderigo A, Chamley LW. Comparison of the
expression of human leucocyte antigen (HLA)-G and HLA-E in women with
normal pregnancy and those with recurrent miscarriage. Reproduction 2006;
131:583e9.
[53] Hiby SE, Walker JJ, O’Shaugnessey KM, Redman CWG, Carrington M, Moffet A.
Combination of maternal KIR and fetal HLA-C genos inﬂuence the risk of pre-
eclampsia and reproductive stress. J Exp Med 2008;200:957e65.
[54] Hiby SE, Regan L, Lo W, Farrell L, Carrington M, Moffet A. Association of
maternal killer-cell immunoglobulin-like receptors and parental HLA-C
genotypes with recurrent miscarriage. Hum Reprod 2008;23:972e6.
[55] Nielsen HS, Andersen A- MN, Kolte AM, Christiansen OB. A ﬁrst born is
suggestive of a strong prognostic factor in secondary recurrent miscarriage:
a conﬁrmatory study. Fertil Steril 2008;89:907e11.
[56] Nielsen HS, Steffensen R, Varming K, van Halteren AGS, Spierings W,
Ryuder LP, et al. Association of HY-restricting HLA class II alleles with preg-
nancy outcome in patients with recurrent miscarriage subsequent to a ﬁrst-
born boy. Hum Mol Genet 2009;18:1684e91.
[57] Zenclusen AC, Gerlof K, Zenclusen ML, Sollwedel A, Bertoja AZ, Ritter T, et al.
Abnormal T cell reactivity against paternal antigens in spontaneous abortion:
adoptive transfer of pregnancyeinduced CD4þCD25þ T regulatory cells prevents
fetal rejection in a murine abortion model. Am J Pathol 2005;166:811e22.
[58] Jin L-P, Zhou Y-H, Zhu X-Y, Wang M-Y, Li D-J. Adoptive transfer of paternal
antigen-hyporesponsive T cells facilitates a Th2 bias in peripheral lympho-
cytes and at materno-fetal interface in murine abortion-prone matings. Am J
Reprod Immunol 2006;56:258e66.
[59] Schumacher A, Wafula PO, Bertoja AZ, Sollwedel A, Thuere C, Wollenberg I,
et al. Mechanism of action of regulatory T cells speciﬁc for paternal antigens
during pregnancy Obstet. Gynecol 2007;110:1137e45.
S. Scherjon et al. / Placenta 32 (2011) S291eS297 S297[60] Yang H, Qiu L, Chen G, Ye Z, LüC Lin Q. Proportional changes of CD4þCD25þ
regulatory T cells in decidua and peripheral blood in unexplained recurrent
spontaneous abortion patients. Fertil Steril 2008;89:656e61.
[61] Mei S, Tan J, Chen H, Chen Y, Zhang J. Changes of CD4þCD25high regulatory T
cells and FOXP3 expression in unexplained recurrent spontaneous abortion
patients. Fertil Steril 2010;94:2244e7.
[62] Dekker GA, Robillard PY, Hulsey TC. Immune maladaptation in the etiology of
pre-eclampsia: a review of corroborative epidemiological studies. Obstet Gyn
Surv 1998;53:377e82.
[63] Berends AL, Steegers ES, Isaacs A, Aulchenko YS, Liu F, de Groot CJ, et al. Familial
aggregation of preeclampsia and intrauterine growth restriction in a genetically
isolated population in The Netherlands. Eur J Hum Genet 2008;16:1437e42.
[64] De Luca Brunori I, Battini L, Simonelli M, Brunori E, Valentino V, Curcio M,
et al. HLA-DR in couples associated with preeclampsia: background and
updating by DNA sequencing. J Reprod Immunol 2003;59:235e43.
[65] Kilpatrick DC, Liston WA, Gibson F, Livingstone J. Association between suscep-
tibility to pre-eclampsia within families and HLA DR4. Lancet; 1989:1063e4.
[66] Saftlas AF, Beydoun H, Triche E. Immunogenetic determinants of preeclampsia
and related pregnancy disorders. A systematic review. Obstet Gynecol 2005;
162:162e72.[67] Dehaghani AS, Doroudchi M, Kalantari T, Pezeshki AM, Ghaderi A. Heterozy-
gosity in the CTLA-4 gene and severe preeclampsia. Int J Gynecol Obstet 2005;
88:19e24.
[68] Haggerty CL, Ferrell RE, Hubel CA, Markovic N, Harger G, Ness RB. Association
between allelic variants in cytokine genes and pre-eclampsia. Am J Obstet
Gynaecol 2005;193:209e15.
[69] Prins JR, Boelens HM, Heimweg J, Van der Heide S, Dubois AE, Van
Oosterhout AJ, et al. Preeclampsia is associated with lower percentages
of regulatory T cell in maternal blood. Hypertens Pregnancy 2009;28:
300e11.
[70] Steinborn A, Haensch G, Mahnke K, Schmiktt W, Toemr A, Mauer S, et al.
Distict subsets of regulatory T cells during pregnancy: is the imbalance of
these subsets involved in the pathogenesis of preeclampsia? Clin Immunol
2008;129:401e12.
[71] Darmochwal-Kolarz D, Saito S, Rolinski J, Tabarkiewicz J, Kolarz B, Lesczynska-
Gorzelak B, et al. Activated T lymphocytes in pre-eclampsia. Am J Reprod
Immunol 2007;58:39e45.
[72] Sasaki Y, Darmochwal-Kolarz D, Suzuki D, Sakai M, Ito M, Shima T, et al.
Proportion of peripheral blood and decidual CD4(þ)CD25(bright) regu-
latory T cells in pre-eclampsia. Clin Exp Immunol 2007;149:139e45.
